Cancer News and Research

Latest Cancer News and Research

ONA credits cancellation of RN cuts at LHSC's cancer care program to community, London RNs

The Ontario Nurses' Association (ONA) credits the cancellation of cuts to registered nurses at London Health Sciences Centre's cancer care program, in large part, to the determination of the community.

3 Jul 2010

Rogue stem cells capable of kick-starting melanoma skin cancer development discovered

Researchers at Stanford University School of Medicine in the US have discovered that rogue stem cells appear to be capable of kick-starting the development of melanoma skin cancer in humans.

3 Jul 2010

Pennsylvania Department of Health announces new study on blood disorder Polycythemia vera

The Pennsylvania Department of Health today announced a new, federally-funded study on the blood disorder Polycythemia vera, or PV, in Bedford, Blair, Cambria and Somerset counties.

3 Jul 2010

Cancer Research UK raises £200,000 in Network Rail partnership celebrations

Cancer Research UK, the world's leading charity dedicated to cancer research, is celebrating after the launch of its new two-year partnership with Network Rail got off to a flying start, raising almost £200,000 in the first three months of the partnership.

3 Jul 2010

Heart patients treated for lymphoma at increased risk of cardiac problems

Older patients with Hodgkin lymphoma (HL) and a history of heart disease face a high risk of hospitalization for cardiac complications after completing treatment, according to research published online today in Blood, the journal of the American Society of Hematology. HL is a form of cancer of arising in the lymph nodes, and approximately 8,500 people were diagnosed with the disease in 2009, according to the American Cancer Society.

3 Jul 2010

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.

From Elekta 3 Jul 2010

MabCent finds extraordinary life forms in the Arctic

During its short existence the Centre on Marine Bioactives and Drug Discovery (MabCent) in Tromsø has analysed some 70,000 fractions of Arctic marine organisms. Patents on two molecules have been applied for and applications for another 20 will soon follow.

3 Jul 2010

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Neogenix Oncology announced today that its registration statement on Form 10 as amended, filed with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, has become effective. The Form 10 includes a description of the business of the company, management's discussion and analysis of financial condition, financial statements for the past two years and the first quarter of 2010, as well as other legal and financial disclosures such as risk factors.

3 Jul 2010

ZERO demands ACS apology on effectiveness of PSA test

With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO – The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing.

3 Jul 2010

Neogenix Oncology files patent application with USPTO for 16C3 antigen

Neogenix Oncology announced today that the company has filed a patent application with the U.S. Patent and Trade Office (USPTO) for the 16C3 antigen. The Company believes that this antigen is tumor specific for pancreatic and colorectal tumors; and, based on preliminary clinical data, may also have diagnostic utility as a biomarker for these cancers.

3 Jul 2010

People with high levels of vitamin B6 and methionine less likiely to develop lung cancer

People with higher blood levels of vitamin B6 and the amino acid methionine appear to have a lower risk of lung cancer, a French study has found. But more research is needed to understand if higher levels of the nutrients directly protect against the disease.

3 Jul 2010

Overweight girls less likely to develop breast cancer in later life

Women who recall carrying excess body fat during childhood and adolescence appear to be less likely to develop breast cancer in later life, a US study reports.

3 Jul 2010

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Endo Pharmaceuticals today announced the successful completion of the tender offer by its wholly owned subsidiary, HT Acquisition Corp., for all of the outstanding shares of common stock of HealthTronics, Inc..

3 Jul 2010

Strativa receives FDA approval for Zuplenz oral soluble film

Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.

3 Jul 2010

WaferGen Biosystems to raise $7 million in registered direct offering

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced that it has received commitments from certain investors to purchase approximately $7 million of previously unissued securities in a registered direct offering. The investors include the Chairman and CEO, Alnoor Shivji, who has agreed to purchase $1 million of securities in the registered direct offering.

2 Jul 2010

Eli Lilly, Alnara sign definitive merger agreement

Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT).

2 Jul 2010

Studies demonstrate analgesic properties of synthetic cannabinoid

A new compound similar to the active component of marijuana (cannabis) might provide effective pain relief without the mental and physical side effects of cannabis, according to a study in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jul 2010

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Just one year after The University of Texas MD Anderson Cancer Center launched its secured, Web-based portal for personal health information, more than 28,000 patients (57 percent) who logged into myMDAnderson - a personalized, online connection to the center - have accessed their personal medical information, test results and records.

2 Jul 2010

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

Utilizing Fluidigm Corporation's Dynamic Array™ and Digital Array™ integrated fluidic circuits (IFCs), Stanford University researchers to have discovered a much larger spectrum of differences between individual cells than has previously been demonstrated. Among these differences are the communication capabilities that emerge from the interactions of genetic circuitry that mediates cell-to-cell communication.

2 Jul 2010

Modified Citrus Pectin holds promise against prostate cancer

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

2 Jul 2010

Cancer News and Research

Latest Cancer News and Research

ONA credits cancellation of RN cuts at LHSC's cancer care program to community, London RNs

Rogue stem cells capable of kick-starting melanoma skin cancer development discovered

Pennsylvania Department of Health announces new study on blood disorder Polycythemia vera

Cancer Research UK raises £200,000 in Network Rail partnership celebrations

Heart patients treated for lymphoma at increased risk of cardiac problems

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

MabCent finds extraordinary life forms in the Arctic

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

ZERO demands ACS apology on effectiveness of PSA test

Neogenix Oncology files patent application with USPTO for 16C3 antigen

People with high levels of vitamin B6 and methionine less likiely to develop lung cancer

Overweight girls less likely to develop breast cancer in later life

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Strativa receives FDA approval for Zuplenz oral soluble film

WaferGen Biosystems to raise $7 million in registered direct offering

Eli Lilly, Alnara sign definitive merger agreement

Studies demonstrate analgesic properties of synthetic cannabinoid

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

Modified Citrus Pectin holds promise against prostate cancer

Industry Focus eBook: Oncology eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook: Oncology eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in